- Assistant Professor, CWRU School of Medicine
- Associate Medical Director, Pediatric Infection Control, UH Rainbow Babies and Children's Hospital
Amy M. Edwards, MD, is a physician in the Division of Pediatric Infectious Diseases and is associate medical director for Infection Control at University Hospitals Rainbow Babies & Children's Hospital. She is assistant professor, Pediatrics at Case Western Reserve University School of Medicine.
Dr. Edwards is board certified in pediatrics and pediatric infectious diseases. Her special interest is in prevention of hospital-acquired infection and in transplant infectious diseases.
She earned her undergraduate degree with honors from Georgia Institute of Technology in Atlanta and received her medical degree from the Medical School for International Health, Ben Gurion University, Beer Sheva, Israel. Dr. Edwards completed her pediatric residency at MetroHealth Medical Center in Cleveland, and a fellowship in pediatric infectious diseases at UH Rainbow Babies & Children's Hospital.
Dr. Edwards joined the UH Rainbow Babies & Children's Hospital staff in 2013. Her research interests include the appropriate use of antibiotics in neutropenic and non-neutropenic patients with fever and a central line, and the use of quality metrics to improve patient outcomes.
Dr. Edwards is a member of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society and American Academy of Pediatrics.
- Pediatric Infectious Diseases - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Fellowship | Pediatric Infectious Diseases
Pediatric Infectious Diseases - Uh Rainbow Babies And Children's Hospital (2010 - 2013)
Residency | Pediatrics
Pediatrics - Metrohealth Medical Center (2007 - 2010)
Ben-Gurion University Of The Negev (2007)
Georgia Institute Of Technology (2001)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Amy Edwards did not disclose any Outside Relationships with Industry.